BioAge Labs (BIOA) Change in Accured Expenses (2023 - 2026)

BioAge Labs has disclosed Change in Accured Expenses across 4 years of filings, most recently posting -$3.8 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$3.8 million, up 44.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$306000.0 (down 116.97% YoY), and the FY2025 annual result was -$3.4 million, down 173.73% from the prior year.
• Change in Accured Expenses came in at -$3.8 million for Q1 2026 at BioAge Labs, down from $1.4 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $8.2 million in Q3 2024 to a low of -$6.9 million in Q1 2025.
• The 4-year median for Change in Accured Expenses is $406000.0 (2025), against an average of $38200.0.
• Peak annual rise in Change in Accured Expenses reached 264.55% in 2025, while the deepest fall reached 106.61% in 2025.
• BioAge Labs' Change in Accured Expenses stood at $3.0 million in 2023, then decreased by 26.59% to $2.2 million in 2024, then tumbled by 38.71% to $1.4 million in 2025, then slumped by 383.83% to -$3.8 million in 2026.
• The last three Change in Accured Expenses figures came in at -$3.8 million (Q1 2026), $1.4 million (Q4 2025), and -$542000.0 (Q3 2025), per Business Quant data.